Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06648278 · ClinicalTrials.gov registry record · NA

Patient Care Outreach, Navigation, Technology and Support 2.0

A NA study of Breast Cancer and Cardiovascular Diseases, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
260
Enrollment target
2
Study locations

NCT06648278: Recruiting NA study of Breast Cancer and Cardiovascular Diseases, sponsored by University of California, San Francisco.

NCT06648278 is a NA study of Breast Cancer and Cardiovascular Diseases that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 260 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06648278, a NA study of Breast Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
260 participants
Enrollment target
2
Study locations

Study Summary

This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.

Primary Outcome

Participant satisfaction will be assessed via a response of "satisfied" or "very satisfied" to survey item on satisfaction with Patient COUNTS navigation program

Interventions

  • OTHER Survey Administration
  • BEHAVIORAL Patient Navigation Program
  • OTHER Quality-of-Life (QOL) Assessment

Study Locations (2)

California

  • Zuckerberg San Francisco General Hospital - San Francisco
  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2023-08-10
Est. Completion 2027-02-28
Phase NA

What NCT06648278 shows while recruiting

NCT06648278 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT06648278 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06648278 about?

NCT06648278 is a clinical study titled "Patient Care Outreach, Navigation, Technology and Support 2.0". This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserve...

What is the current status of trial NCT06648278?

This trial is currently recruiting. It is a NA study. The enrollment target is 260 participants. The study started on 2023-08-10. Estimated completion is 2027-02-28.

What conditions does trial NCT06648278 study?

This clinical trial studies the following conditions: Breast Cancer, Cardiovascular Diseases.

What interventions are being tested in trial NCT06648278?

The interventions under investigation include: Survey Administration (OTHER), Patient Navigation Program (BEHAVIORAL), Quality-of-Life (QOL) Assessment (OTHER).

Who is sponsoring clinical trial NCT06648278?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06648278 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06648278's enrollment target sits among peer trials

260 313th of 1224 higher than 909 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02283996 · 260 participants · Phase 4

    Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

  • NCT03276793 · 260 participants · NA

    Brain Connectivity in Depression

  • NCT03407469 · 260 participants

    Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

  • NCT03713125 · 260 participants · NA

    Executive Function in Early Childhood

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06648278, the US trial registry maintained by the National Library of Medicine. NCT06648278 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.